MedinCell announces the initiation of coverage of its stock by ODDO-BHF
July 26, 2021
MedinCell announces fiscal year consolidated results April 2020 – March 2021
June 16, 2021
MedinCell’s Long-Acting Injectable to fight Malaria ready to enter Regulatory Development
June 14, 2021
Videoconference and publication of the results for the 2020-2021 financial year, on June 16, 2021
June 1, 2021
Clinical trial conducted by MedinCell confirms the safety of continuous administration of ivermectin
April 19, 2021
Covid-19: MedinCell publishes an extensive Ivermectin Safety Expert Analysis
March 5, 2021
Tremendous success for MedinCell’s €30 million capital increase for qualified investors
February 11, 2021
MedinCell announces a capital increase of a c.€30 million
February 10, 2021
Publication of the 2021 financial calendar
February 1, 2021
MedinCell announces the transfer of its shares from compartment C to compartment B of Euronext Paris
January 28, 2021
